Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
Breaking Barriers: Healthcare Distributors Celebrate Women's History Month
As the healthcare distribution industry continues to focus on the importance of diversity and belonging in the sector, we celebrate Women’s History Month to honor the social, economic, cultural and political contributions of women and girls throughout history.
The increasing number of female healthcare supply chain professionals contributes immense value and expertise to the healthcare system. In the spirit of this month’s national observance, we explore some of the ways HDA and our members are working to recognize the achievements of our female colleagues and foster a culture of gender parity.
HDA Distributors Proud to Partner With Pharmacists Each Step of the Way
October marks American Pharmacists Month, an important opportunity to recognize the profound contribution of dedicated pharmacists who work on the frontlines of U.S. healthcare on a daily basis.
Transitioning COVID-19 Product Distribution to the Commercial Market
Throughout the COVID-19 pandemic, the federal government has primarily coordinated response efforts with the support of the private sector to develop, produce and distribute vaccines, personal protective equipment (PPE) and therapeutics. While this public health crisis continues, government and private-sector stakeholders are already thinking about the expected transition of COVID-19 product distribution to the commercial market — which could happen as early as the first quarter of this year.
HDA Presents 2022 Distribution Management Award to AmerisourceBergen
The Healthcare Distribution Alliance (HDA) honored AmerisourceBergen with the 2022 Distribution Management Award (DMA) in recognition of the company’s collaboration with multiple government and supply chain partners to enable small-practice provider access to the COVID-19 vaccine. The award was presented during the 2022 Distribution Management Conference and Expo in Austin, Texas.
HDA’s Davis Shares 2022 Strategic Priorities Under Increased Awareness of Supply Chains
Events spanning COVID-19 vaccine distribution to shipping containers held up at port have made the supply chain a “kitchen-table” issue during the past year. Many industries experienced notable disruptions in their delivery of goods and supplies; however, as noted by President and CEO Chip Davis, “[P]harmacies, health systems and physicians’ offices, more than 180,000 across the country, remain stocked with the lifesaving medications and vaccines patients need. That didn’t happen by accident.” Davis’ perspective was featured alongside healthcare supply chain association leaders as part of Chain Drug Review’s annual “Pharmacy Outlook” feature.